Definium Therapeutics, formerly Mind Medicine (MNMD), unveiled its new brand. In conjunction with the rebrand, the company’s Nasdaq ticker symbol will change to (DFTX) effective at market open on January 13.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MNMD:
- Psychedelic: Bright Minds reports results from Phase 2 BMB-101 trial
- Needham names Mind Medicine top pick, adds to Conviction List
- Ametek, MindMed, Atai, Prime and KB Home Trending
- MindMed Expands Into Autism: What Investors Should Know About the New MM402 Trial
- Midday Fly By: Wegovy weight loss pill approved, ServiceNow inks security deal